logo

For the Inventor, By the Inventor

Wilmington, DE, United States of America

Wenhua Xiao

This inventor holds 6 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2004-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wenhua Xiao. Retrieved from https://idiyas.com/inventor/wenhua-xiao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 16.7

Average Co-Inventor Count = 7.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Wilmington, DE (US) (2004 - 2005)
  • Montreal, CA (2004 - 2005)

Company Filing History:

goldMedal6 out of 1,534 
 
Astrazeneca Ab
 patents

Years Active: 2004-2005

Loading Chart...
6 patents (USPTO):Explore Patents
1. 6946463 - 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain (2005-09-20),
2. 6943165 - Compound and method for the treatment of pain (2005-09-13),
3. 6933297 - 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione and the use thereof for the treatment of pain (2005-08-23),
4. 6833368 - 1, 2, 5, 10-tetrahydropyridazino[4, 5-b]quinoline-1,10-diones and their use for the treatment of pain (2004-12-21),
5. 6787547 - Compound and method for the treatment of pain (2004-09-07),
6. 6730675 - Compounds and methods for the treatment of pain (2004-05-04),

Title: **Wenhua Xiao: Innovator in Pain Management Solutions**

Introduction

Wenhua Xiao is a prominent inventor based in Wilmington, DE, who has made significant contributions to the field of pharmaceuticals, specifically in pain management. With a total of six patents to his name, his work reflects a commitment to developing innovative solutions aimed at alleviating pain.

Latest Patents

Wenhua Xiao’s latest patents include the development of novel compounds known as 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones, which are designed for the treatment of pain. The examiner's statement for one of these patents noted that through amendments to the claims, 'E' was limited to phenyl or cycloalkyl groups, effectively addressing previous rejections related to alkyl compounds. Another noteworthy patent describes a compound, 7-chloro-4-hydroxy-2-(2-chloro-4-methylphenyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione, along with pharmaceutically acceptable salts for treating pain, highlighting the innovative methods of employing these compounds in therapeutic applications.

Career Highlights

Wenhua currently works at AstraZeneca AB, a leading global biopharmaceutical company known for its innovative approach to drug development. His tenure at AstraZeneca has allowed him to engage deeply in research and development initiatives targeting pain management, reflecting his expertise and dedication to improving patient outcomes.

Collaborations

Throughout his career, Wenhua has collaborated with numerous colleagues, including Thomas Michael Bare and Dean Brown. These collaborations have contributed to the exchange of ideas and expertise, further enhancing the research endeavors within the company and promoting advancements in pharmaceutical innovations.

Conclusion

Wenhua Xiao stands out as a key inventor in the realm of pharmaceutical innovation, particularly in pain treatment solutions. With an impressive portfolio of patents and collaborative efforts, he continues to contribute meaningfully to the development of effective pain management therapies. His work is a testament to the importance of innovation in healthcare and the ongoing quest to improve quality of life for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…